GlassScriptPhysician profile
Sayena Azarbar
NPI 1447795646
$5,966.91
in general payments reported to CMS, 2019-2025
29 companies · $2,946 in 2025
The $2,946 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $396 · 2021: $16.68 · 2022: $224 · 2023: $1,345 · 2024: $541 · 2025: $2,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,182 · Travel and Lodging: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,182.22 |
| Travel and Lodging | $1,649.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,227.91 | 2023-2025 | Triclip, Jot Dx, Cardiomems |
| Janssen Pharmaceuticals, INC | $444.81 | 2019-2023 | Xarelto |
| Alnylam Pharmaceuticals INC. | $373.59 | 2019-2025 | Amvuttra, Onpattro |
| Novartis Pharmaceuticals Corporation | $364.99 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $328.97 | 2019-2025 | Lifevest |
| Abiomed | $320.61 | 2023-2025 | Impella |
| Cvrx, INC. | $247.11 | 2023-2025 | Barostim Neo System |
| Boston Scientific Corporation | $202.20 | 2021-2025 | Watchman Flx, Watchman Access System |
| Amgen INC. | $190.15 | 2019-2022 | |
| Penumbra, INC. | $182.04 | 2023 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $164.08 | 2024-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $129.52 | 2022-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $119.95 | 2019-2025 | Brilinta, Farxiga |
| Novo Nordisk INC | $103.51 | 2023-2025 | Wegovy, Ozempic |
| Inari Medical, INC. | $100.22 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $77.15 | 2025 | |
| Pfizer INC. | $61.36 | 2019-2025 | |
| Heartflow, INC. | $43.16 | 2024 | |
| Galderma Laboratories, L.P. | $41.24 | 2019 | |
| Medtronic Vascular, INC. | $38.20 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $37.24 | 2019 | |
| Irhythm Technologies, INC. | $31.82 | 2020-2023 | Zio Xt Patch |
| Lexicon Pharmaceuticals, INC. | $23.68 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $22.66 | 2025 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $21.46 | 2025 | Arexvy, Shingrix |
| Bardy Diagnostics, INC. | $21.00 | 2020 | |
| Portola Pharmaceuticals, LLC | $18.25 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.92 | 2025 | |
| Sanofi-Aventis U.S. LLC | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sayena Azarbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.